Article Text

other Versions

PDF
Retinoblastoma: diagnosis and management— the UK perspective
  1. Helen Jenkinson
  1. Correspondence to Dr Helen Jenkinson, Department of Paediatric Oncology, Birmingham Children's Hospital NHS Foundation Trust, Birmingham B4 6NH, UK; helen.jenkinson{at}bch.nhs.uk

Abstract

In the developed world, retinoblastoma is an uncommon yet highly curable ocular malignancy of childhood affecting 40–50 children in the UK each year. The presenting signs, most commonly leukocoria and squint, should alert the primary care physician or secondary care physician to examine for the red reflex, the absence of which is an indication for urgent ophthalmology assessment. Diagnosis is made by clinical examination and staging may include bone marrow sampling, lumbar puncture and MRI scanning. CT should be avoided to reduce radiation exposure in a population of whom a proportion are at considerable risk of second malignancies. Although enucleation is necessary for many children, over recent years there has been a growing emphasis on conservative management in an attempt to reduce the need for enucleation and avoid the adverse late effects associated with external beam radiotherapy. This review will describe approaches to treatment in the UK and how the stage, laterality and position of the tumour within the eye influence treatment choices.

  • Oncology
  • Ophthalmology

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.